Back
Invesco Ltd. 10K Form
Buy
53
IVZ
Invesco Ltd.
Last Price:
$25.20
Seasonality Move:
3.78%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | IVZ/Invesco Ltd. Quarterly |
| 2024-02-21 | 10K | IVZ/Invesco Ltd. Annual |
| 2023-10-31 | 10Q | IVZ/Invesco Ltd. Quarterly |
| 2023-08-02 | 10Q | IVZ/Invesco Ltd. Quarterly |
| 2023-05-03 | 10Q | IVZ/Invesco Ltd. Quarterly |
| 2023-02-23 | 10K | IVZ/Invesco Ltd. Annual |
Receive IVZ News And Ratings
See the #1 stock for the next 7 days that we like better than IVZ
IVZ Financial Statistics
Sales & Book Value
| Annual Sales: | $6B |
|---|---|
| Cash Flow: | $557.1M |
| Price / Cash Flow: | 9.23 |
| Annual Sales: | $24.70 |
| Price / Book: | 1.02 |
Profitability
| EPS (TTM): | 1.47300 |
|---|---|
| Net Income (TTM): | $1.1B |
| Gross Margin: | $3.8B |
| Return on Equity: | 6.87% |
| Return on Assets: | 3.8% |
Invesco Ltd. Earnings Forecast
Key Invesco Ltd. Financial Ratios
-
The Gross Profit Margin over the past 40 years for IVZ is 63.30%.
-
The Selling, General & Administrative Expenses for IVZ have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 7.71% of Operating Income.
-
The Net Earning history of IVZ is 12.52% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 20 years.
Invesco Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Capital Markets |
| Sector: | Financials |
| Current Symbol: | IVZ |
| CUSIP: | G491BT |
| Website: | invesco.com |
Debt
| Debt-to-Equity Ratio: | 0.6 |
|---|---|
| Current Ratio: | 0.98 |
| Quick Ratio: | 0.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 21.42 |
|---|---|
| Forward P/E Ratio: | 10.19 |
IVZ Technical Analysis vs Fundamental Analysis
Buy
53
Invesco Ltd. (IVZ)
is a Buy
Is Invesco Ltd. a Buy or a Sell?
-
Invesco Ltd. stock is rated a BuyThe current Invesco Ltd. [IVZ] share price is $25.21. The Score for IVZ is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.